Home > Healthcare > Healthcare IT > Health Services > Home Healthcare Market
Home Healthcare Market size accounted for USD 262.5 billion in 2022 and is estimated to grow at 7.9% to reach USD 555.6 billion by 2032. Increasing prevalence of target diseases, especially Alzheimer’s & dementia, growing need for cost effective healthcare delivery, and rapid technological advancements are some of the drivers fostering the market growth.
Additionally, the growing geriatric population is one of the significant factors in driving the market expansion. For instance, according to the World Health Organization (WHO) report, in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. Therefore, geriatric population are more susceptible to chronic conditions that will necessitate long-term care, will supplementing the market progress. Global pediatric home healthcare industry is estimated to grow at 7.6% CAGR between 2023 and 2032 due to increasing prevalence of chronic ailments among infants.
Home healthcare refers to a range of medical, therapeutic, and support services provided to individuals in the comfort and convenience of their own homes. It involves the delivery of personalized and comprehensive healthcare solutions to patients who may have difficulty accessing traditional healthcare settings due to age, illness, or mobility limitations.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Home Healthcare Market Size in 2022: | USD 262.5 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 7.9% |
2032 Value Projection: | USD 555.6 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 220 |
Tables, Charts & Figures: | 457 |
Segments covered: | Component, Indication, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
With the increasing number of COVID-19 cases, several local and national regulatory bodies imposed stringent restrictions on the movement of people and goods. This caused significant disruptions in the normal workflow of almost all sectors, disrupting the global supply chain network. The COVID-19 pandemic largely affected the overall healthcare sector globally, leading to postponement and suspensions of treatment and diagnosis of non-essential conditions. However, the COVID-19 pandemic boosted the overall adoption of home healthcare across geographies. The imposed restrictions were noted to affect individuals with significantly increased reports relating to isolation, insomnia, anxiety, depression, fear, frustration as well as substance abuse, leading to an increased prevalence of chronic conditions and behavioral disorders.
The growing prevalence of target diseases, particularly Alzheimer's and dementia, is expected to be a significant market growth. As the global population ages and life expectancy increases, there has been a substantial rise in the number of individuals affected by these neurodegenerative conditions. For instance, according to the National Institutes of health (NIH) report, Alzheimer is the sixth-leading cause of death in the U.S. and the fifth-leading cause of death among Americans aged 65 and older. An estimated of 6.2 million Americans aged 65 and older are living with Alzheimer's dementia (AD). This number could grow to 13.8 million by 2060 barring the development of medical breakthroughs to prevent, slow or cure AD. Thus, increasing prevalence of AD is creating a higher demand for specialized care services, including home healthcare to support patients and their families, thereby fostering the market progress.
Changing reimbursement policies may restraint the market growth. Reimbursement policies play a crucial role in determining the financial viability of home healthcare services. Any modifications or adjustments to these policies can have a direct impact on the revenue and profitability of home healthcare providers. Changes in reimbursement rates, restrictions on covered services, or increased administrative burdens can create financial challenges for businesses in the sector. Moreover, the complexity and variability of reimbursement policies across different regions may hamper the market revenue.
By component, the home healthcare market is classified into product and services. The services segment accounted for 78.3% of the business share in 2022 and is projected to witness robust growth over the analysis timeframe. As the demand for home-based healthcare services continues to rise, there is a growing necessity for a wide range of specialized services to cater to diverse patient needs. Home healthcare providers are expanding their service offerings to include a comprehensive range of medical, therapeutic, and support services. These may include skilled nursing care, physical therapy, occupational therapy, speech therapy, wound care, medication management, palliative care, and chronic disease management, among others. By offering an extensive portfolio of services, home healthcare providers can effectively address the complex healthcare requirement of patients, providing holistic and personalized care at homes.
Based on indication, the home healthcare market is segmented into cardiovascular disorder, hypertension, diabetes, respiratory disease, cancer, maternal disorders, trauma, renal disorders, neurovascular disorders, mobility disorders, and other indications. The diabetes segment is expected to register around USD 131 billion by 2032. With the escalating prevalence of diabetes globally, there is an increasing demand for specialized home-based healthcare diabetes care devices tailored to effectively manage this chronic condition.
For instance, as per International Diabetes Federation report, in 2021, approximately 537 million adults (20-79 years) were living with diabetes. Hence, home healthcare providers are diversifying their range of services and products to offer comprehensive solutions for diabetes management. These solutions include remote glucose monitoring, administering insulin with insulin delivery devices, managing medications, providing nutritional guidance, and offering lifestyle counselling. Therefore, with the help of these solutions’ healthcare providers can remotely monitor blood sugar levels, offer real-time guidance, and provide personalized support to individuals with diabetes, thereby boosting the market size.
North America home healthcare market accounted for 48% business share in 2022 and is anticipated to grow at considerable growth rate during the forecast timeframe. Some of the main factors driving this market include the sizeable ageing population coupled with advanced healthcare system and relatively high disposable incomes. Also, the rising prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and respiratory disorders, will further drive the need for specialized care in the comfort of patients home.
For instance, according to the American Heart Association report, cardiovascular disease (CVD) remain as the leading cause of death in the U.S., accounted for 928,741 deaths in the year 2020. Thus, increasing use of home healthcare products and services in the treatment of chronic diseases will escalate the market growth. Moreover, advancements in technology have gained significant traction in North America enabling healthcare professionals to deliver high-quality care remotely.
Major market players operating in the home healthcare market include :
These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
Click here to Buy Section of this Report
By Component
Application
The above information is provided for the following regions and countries: